TABLE 2.
No. | Wt. %† | 95% CI | |
---|---|---|---|
Threshold for initiating ART if no barriers or contraindications to ART: | |||
Treat regardless of CD4 count | 889 | 71.2 | 64.6 to 77.8 |
CD4 count <200 cells/mm3 | 9 | 1.2‡ | 0.1 to 2.3 |
CD4 count <350 cells/mm3 | 62 | 8.7 | 5.2 to 12.1 |
CD4 count <500 cells/mm3 | 221 | 18.9 | 14.3 to 23.5 |
Percentage of patients for whom provider currently defers, for any reason, prescribing ART | |||
0% | 130 | 17.0 | 12.7 to 21.4 |
1%–10% | 863 | 69.6 | 64.9 to 74.3 |
Over 10% | 178 | 13.3 | 9.5 to 17.2 |
Among patients for whom they defer prescribing ART, percentage of providers who cite factor for at least half of patients | |||
Patient refusal or unwillingness to commit to treatment | 657 | 59.4 | 53.8 to 65.0 |
Patient has medical problem that may make long-term adherence difficult (eg, substance abuse, mental health, or other illness) | 333 | 31.1 | 26.8 to 35.4 |
Patient has social issue that may make long-term adherence difficult (eg, homeless, incarcerated, migrant) | 243 | 21.4 | 17.3 to 25.5 |
Inability to pay for medications or medication coverage delays | 80 | 10.5 | 4.1 to 16.9 |
Inability to construct an effective regimen with acceptable side effects | 23 | 1.4‡ | 0.5 to 2.2 |
Does not agree with current guidelines to treat HIV-infected patients at all CD4 levels | 30 | 3.2‡ | 0.7 to 5.7 |
Practice provides on-site adherence counseling | 927 | 54.2 | 43.9 to 64.6 |
Practice provides on-site mental health services | 799 | 45.1 | 36.8 to 53.4 |
Practice provides on-site substance abuse treatment | 433 | 23.5 | 17.3 to 29.6 |
Practice provides on-site case management | 850 | 50.8 | 41.5 to 60.1 |
Practice uses an integrated team | 874 | 54.1 | 45.6 to 62.6 |
Facility uses an electronic medical record | 759 | 62.2 | 48.9 to 75.5 |
The number of eligible providers who indicated on the survey that they prescribed ART was 1999.
Values exclude “don’t know” responses.
Coefficient of variation is greater than 0.30, estimate may be unreliable.
Wt., weighted.